We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Some Transfusions May Do More Harm Than Good

By LabMedica International staff writers
Posted on 09 May 2012
The lack of clear guidelines for ordering blood transfusions means there is still wide variation in the use of transfusions and frequent use of transfused blood in patients who do not need it. More...


The resulting overuse of blood is problematic because blood is a scarce and expensive resource and because recent studies have shown that surgical patients do no better, and may do worse, if given transfusions prematurely or unnecessarily.

Scientists at Johns Hopkins University School of Medicine (Baltimore, MD, USA) examined the electronic anesthesia records of more than 48,000 surgical patients at the adjacent Johns Hopkins Hospital over the 18 months from February 2010 to August 2011. Overall, 2,981 patients (6.2%) were given blood transfusions during surgery. The study found wide variation among surgeons and among anesthesiologists, compared to their peers, and how quickly they order blood.

In a healthy adult, a normal hemoglobin level, the quantity of red blood cells carrying oxygen through the body, is approximately 14 g/dL. The guidelines state that when a patient's hemoglobin level falls below 6 or 7 g/dL, a patient will benefit from a transfusion and that if the levels are above 10, a patient does not need a transfusion. But when blood levels are in-between, there has been little consensus about what to do. The study found that the use of erythrocyte salvage, fresh frozen plasma, and platelets varied threefold to fourfold among individual surgeons compared with their peers performing the same surgical procedure.

Blood transfusion, which introduces foreign substances into the body, initiates a series of complex immune reactions. Patients often develop antibodies to transfused red blood cells making it more difficult to find a match if future transfusions are needed. Transfused blood also has a suppressive effect on the immune system, which increases the risk of infections, including pneumonia and sepsis.

Blood is in short supply and expensive. In the USA it costs USD 278 to buy a unit of blood from the American Red Cross (Washington DC, USA) for example, and as much as USD 1,100 for the nonprofit to acquire, test, store and transport. The US national social insurance program, Medicare pays just USD 180 for that unit of blood.

Steven M. Frank, MD, leader of the study, said, "Transfusion is not as safe as people think. Over the past five years, studies have supported giving less blood than we used to, and our study shows that practitioners have not caught up. Blood conservation is one of the few areas in medicine where outcomes can be improved, risk reduced, and costs saved all at the same time. Nothing says it's better to give a patient more blood than is needed.” The study was published on April 23, 2012, in the journal Anesthesiology.

Related Links:

Johns Hopkins University School of Medicine
American Red Cross



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Thyroid Test
Anti-Thyroid EIA Test
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.